HANGZHOU, China, May 8, 2023 /PRNewswire/ -- Chance Pharmaceuticals and Acorda Therapeutics, Inc. today announced that they have entered into distribution and supply agreements to provide INBRIJA^® in Greater China (Mainland China, Taiwan, Hong Kong, and Macao). INBRIJA is indicated in the United States for the intermittent treatment of...